JP2015522049A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522049A5
JP2015522049A5 JP2015520915A JP2015520915A JP2015522049A5 JP 2015522049 A5 JP2015522049 A5 JP 2015522049A5 JP 2015520915 A JP2015520915 A JP 2015520915A JP 2015520915 A JP2015520915 A JP 2015520915A JP 2015522049 A5 JP2015522049 A5 JP 2015522049A5
Authority
JP
Japan
Prior art keywords
weight
formulation
amount
alcohol
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520915A
Other languages
English (en)
Japanese (ja)
Other versions
JP6259454B2 (ja
JP2015522049A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/064123 external-priority patent/WO2014009241A1/en
Publication of JP2015522049A publication Critical patent/JP2015522049A/ja
Publication of JP2015522049A5 publication Critical patent/JP2015522049A5/ja
Application granted granted Critical
Publication of JP6259454B2 publication Critical patent/JP6259454B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520915A 2012-07-12 2013-07-04 ジクロフェナク製剤 Active JP6259454B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12176115 2012-07-12
EP12176115.9 2012-07-12
PCT/EP2013/064123 WO2014009241A1 (en) 2012-07-12 2013-07-04 Diclofenac formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017182383A Division JP6434104B2 (ja) 2012-07-12 2017-09-22 ジクロフェナク製剤

Publications (3)

Publication Number Publication Date
JP2015522049A JP2015522049A (ja) 2015-08-03
JP2015522049A5 true JP2015522049A5 (OSRAM) 2016-06-16
JP6259454B2 JP6259454B2 (ja) 2018-01-10

Family

ID=48741196

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015520915A Active JP6259454B2 (ja) 2012-07-12 2013-07-04 ジクロフェナク製剤
JP2017182383A Active JP6434104B2 (ja) 2012-07-12 2017-09-22 ジクロフェナク製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017182383A Active JP6434104B2 (ja) 2012-07-12 2017-09-22 ジクロフェナク製剤

Country Status (14)

Country Link
US (2) US9999590B2 (OSRAM)
EP (2) EP3275466A1 (OSRAM)
JP (2) JP6259454B2 (OSRAM)
KR (1) KR20150030752A (OSRAM)
CN (1) CN104428003B (OSRAM)
AU (1) AU2013289403B2 (OSRAM)
BR (1) BR112015000329A2 (OSRAM)
CA (1) CA2878784A1 (OSRAM)
HK (1) HK1204973A1 (OSRAM)
IL (1) IL236304A0 (OSRAM)
MX (1) MX2015000541A (OSRAM)
NZ (1) NZ702967A (OSRAM)
RU (1) RU2014152445A (OSRAM)
WO (1) WO2014009241A1 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10813897B2 (en) * 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
JP6259454B2 (ja) * 2012-07-12 2018-01-10 フェリング ベスローテン フェンノートシャップ ジクロフェナク製剤
US9855234B2 (en) * 2014-07-08 2018-01-02 Insys Development Company, Inc. Diclofenac sublingual spray
US11020356B2 (en) 2016-12-28 2021-06-01 Hisamitsu Pharmaceutical Co., Inc. Drug-containing patch
WO2018141662A1 (en) * 2017-01-31 2018-08-09 Grünenthal GmbH Administration regimen for a pharmaceutical patch comprising lidocaine and diclofenac
WO2018163176A1 (en) * 2017-03-07 2018-09-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Topical delivery systems for active compounds
KR20190101140A (ko) * 2018-02-22 2019-08-30 동아제약 주식회사 비스테로이드성 소염진통 활성성분을 함유하는 필름 형성 약제학적 조성물
CN111867574B (zh) 2018-02-27 2023-08-04 久光制药株式会社 含有双氯芬酸的乳化凝胶组合物
WO2020171727A2 (en) * 2019-02-19 2020-08-27 Bluepharma - Industria Farmacêutica, S.A. Mucoadhesive compositions and uses thereof
JP6761553B1 (ja) * 2020-02-12 2020-09-23 久光製薬株式会社 ジクロフェナクナトリウム含有貼付剤
JP6744512B1 (ja) * 2020-02-12 2020-08-19 久光製薬株式会社 ジクロフェナクナトリウム含有貼付剤
CN115279360A (zh) * 2020-02-27 2022-11-01 费灵有限公司 局部用双氯芬酸组合物和方法
JP2022096994A (ja) * 2020-12-18 2022-06-30 小林製薬株式会社 外用医薬組成物
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis
IT202100016751A1 (it) * 2021-06-25 2022-12-25 Altergon Sa Formulazione topica di diclofenac ad elevato tasso di assorbimento
JP2024538604A (ja) 2021-10-01 2024-10-23 ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・ワン,エルエルシー 局所適用のための親水コロイドブレンド組成物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
PE20040321A1 (es) 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
US20040096569A1 (en) 2002-11-15 2004-05-20 Barkalow David G. Edible film products and methods of making same
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
EP1670433B1 (en) * 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
US8158152B2 (en) 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
GB0524958D0 (en) 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents
ES2804472T3 (es) 2005-12-13 2021-02-08 Harvard College Estructuras para trasplante celular
TW200815045A (en) 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US8623401B2 (en) 2008-03-27 2014-01-07 Fenwafe Inc. Wafer formulation
CN102227211A (zh) * 2008-11-28 2011-10-26 先进控股有限公司 包含双氯芬酸和羟基脂肪酸聚氧化烯烃酯的药物配制剂
KR20110127678A (ko) * 2009-03-11 2011-11-25 코와 가부시키가이샤 진통·항염증제 함유 외용제
BR112012024432A2 (pt) 2010-03-29 2016-05-31 Ferring Bv composição farmacêutica de dissolução rápida
JP6259454B2 (ja) * 2012-07-12 2018-01-10 フェリング ベスローテン フェンノートシャップ ジクロフェナク製剤

Similar Documents

Publication Publication Date Title
JP2015522049A5 (OSRAM)
RU2014152445A (ru) Композиции на основе диклофенака
JP2014503565A5 (OSRAM)
WO2009053741A3 (en) Novel formulation
JP2014530242A5 (OSRAM)
ECSP045140A (es) Formulaciones farmacéuticas derivadas del platino
AR084691A1 (es) Formulacion de uso topico para un inhibidor de jak y metodo para tratar trastorno de la piel
JP2013515002A5 (OSRAM)
RU2015122627A (ru) Кожные композиции, содержащие неприродные гигроскопические аминокислоты
EA201590591A1 (ru) Способ приготовления геля на основе полифенолов гранатовой кожуры для лечения воспалительных заболеваний в гинекологии
JP2012525358A5 (OSRAM)
US9078869B2 (en) Method for treating skin inflammatory diseases
WO2024088153A1 (zh) 托品酸及其衍生物在制备治疗银屑病药物中的用途
CN101433544B (zh) 具有抗炎消肿镇痛作用的外用药物组合物制剂与用途
WO2016181355A1 (en) Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity
WO2017129108A1 (zh) 一种用于治疗皮肤病的硅凝胶
ITBS20120093A1 (it) Composizione cosmetica e/o farmaceutica per il trattamento dell'infiammazione della cute e delle sindromi correlate
WO2010057117A3 (en) Topical transdermal drug delivery compositions
NZ606177A (en) Compositions for the treatment of actinic keratosis
RU2016101152A (ru) Терапевтические агенты для применения в профилактике и/или лечении гиперкинетических двигательных расстройств
CN106456598A (zh) 外用药物组合物
CN112007039A (zh) 一种包含氟西汀和维生素d3或其衍生物的组合物,及其应用
CN101259138A (zh) 局部应用于动物运动系统部位的消炎和镇痛组合物
CN106413699B (zh) 外用药物组合物
CN101803961B (zh) 鱼用创可贴